Astrazeneca And Oxford University
- All
- News
- Videos
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Indian Medical Experts Support Call For Covishield Vaccine Safety Review
A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of the Oxford/AstraZeneca's COVID-19 vaccine, administered in India as Covishield.
-
On Omicron, AstraZeneca Says Booster Effective, Cites Oxford Lab Study
A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
-
Next Virus Could Be More Lethal, Warns Oxford University Covid Vaccine Creator
The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be even more lethal and contagious.
-
Astra Jab Followed By Pfizer, 4 Weeks Apart, Gives Strong Immunity: Study
Mixing doses of Covid-19 vaccines from Pfizer Inc. and AstraZeneca Plc creates a strong immune response, according to results from a University of Oxford study, a finding that could enable greater flexibility in the use of scarce supplies.
-
Third AstraZeneca Shot, 6 Months After Second, Works Great: Study
Delayed second and third doses of the AstraZeneca vaccine boost immunity against COVID-19, a study by Oxford University, which developed the jab with the British-Swedish firm, said on Monday.
-
AstraZeneca Tests Booster Vaccine Against Beta Variant Of Covid
AstraZeneca and the University of Oxford on Sunday began new trials to test a modified vaccine against the Beta variant, which first emerged in South Africa.
-
Oxford Covid Vaccine To Be Tested On Children For First Time
The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday.
-
After Early Hopes AstraZeneca-Oxford Vaccine Suffer Setbacks
The coronavirus vaccine developed in Britain by Oxford University and UK-Swedish pharmaceutical firm AstraZeneca has suffered several setbacks since its development, dampening hopes over its global role in ending the pandemic.
-
AstraZeneca Covid Vaccine Works Against UK Variant: Oxford
AstraZeneca and Oxford University's COVID-19 vaccine has similar efficacy against the British coronavirus variant as it does to the previously circulating variants, the university said on Friday.
-
Oxford Vaccine Gives Good Immune Responses In Elderly, Says Trial Chief
The COVID-19 vaccine developed by Oxford University and AstraZeneca gives good immune responses in older people, even if there is a lack of data about its exact efficacy, Oxford's vaccine trial chief Andrew Pollard said on Wednesday.
-
Myanmar Launches Covid Vaccination Drive, Prioritises Healthcare Workers
Myanmar launched a COVID-19 vaccination programme on Wednesday, with healthcare staff and volunteer medical workers the first to receive shots of the AstraZeneca and Oxford University vaccine donated by India.
-
A Look Inside World's Biggest Vaccine Factory, Serum Institute Of India
The tiny clinking vials supervised by silent PPE-wearing technicians belie the excitement inside the world's largest vaccine manufacturer, the Serum Institute of India, a major player in the fight against coronavirus.
-
Coronavirus Vaccines Explained: How The Two Shots Launching In India Work
India on Saturday will launch one of the world's biggest vaccination programmes with vaccines manufactured in the country - one developed by Oxford University and AstraZeneca, the other by Bharat Biotech International with a state-run institute.
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Indian Medical Experts Support Call For Covishield Vaccine Safety Review
A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of the Oxford/AstraZeneca's COVID-19 vaccine, administered in India as Covishield.
-
On Omicron, AstraZeneca Says Booster Effective, Cites Oxford Lab Study
A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
-
Next Virus Could Be More Lethal, Warns Oxford University Covid Vaccine Creator
The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be even more lethal and contagious.
-
Astra Jab Followed By Pfizer, 4 Weeks Apart, Gives Strong Immunity: Study
Mixing doses of Covid-19 vaccines from Pfizer Inc. and AstraZeneca Plc creates a strong immune response, according to results from a University of Oxford study, a finding that could enable greater flexibility in the use of scarce supplies.
-
Third AstraZeneca Shot, 6 Months After Second, Works Great: Study
Delayed second and third doses of the AstraZeneca vaccine boost immunity against COVID-19, a study by Oxford University, which developed the jab with the British-Swedish firm, said on Monday.
-
AstraZeneca Tests Booster Vaccine Against Beta Variant Of Covid
AstraZeneca and the University of Oxford on Sunday began new trials to test a modified vaccine against the Beta variant, which first emerged in South Africa.
-
Oxford Covid Vaccine To Be Tested On Children For First Time
The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday.
-
After Early Hopes AstraZeneca-Oxford Vaccine Suffer Setbacks
The coronavirus vaccine developed in Britain by Oxford University and UK-Swedish pharmaceutical firm AstraZeneca has suffered several setbacks since its development, dampening hopes over its global role in ending the pandemic.
-
AstraZeneca Covid Vaccine Works Against UK Variant: Oxford
AstraZeneca and Oxford University's COVID-19 vaccine has similar efficacy against the British coronavirus variant as it does to the previously circulating variants, the university said on Friday.
-
Oxford Vaccine Gives Good Immune Responses In Elderly, Says Trial Chief
The COVID-19 vaccine developed by Oxford University and AstraZeneca gives good immune responses in older people, even if there is a lack of data about its exact efficacy, Oxford's vaccine trial chief Andrew Pollard said on Wednesday.
-
Myanmar Launches Covid Vaccination Drive, Prioritises Healthcare Workers
Myanmar launched a COVID-19 vaccination programme on Wednesday, with healthcare staff and volunteer medical workers the first to receive shots of the AstraZeneca and Oxford University vaccine donated by India.
-
A Look Inside World's Biggest Vaccine Factory, Serum Institute Of India
The tiny clinking vials supervised by silent PPE-wearing technicians belie the excitement inside the world's largest vaccine manufacturer, the Serum Institute of India, a major player in the fight against coronavirus.
-
Coronavirus Vaccines Explained: How The Two Shots Launching In India Work
India on Saturday will launch one of the world's biggest vaccination programmes with vaccines manufactured in the country - one developed by Oxford University and AstraZeneca, the other by Bharat Biotech International with a state-run institute.
